PPA
WX

Parametric Portfolio Associates’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Parametric Portfolio Associates’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-260,502
Closed -$11.3M – 4033
2015
Q3 		$11.3M Sell
260,502
-355
-0.1% -$15K 0.02% 704
2015
Q2 		$11M Sell
260,857
-13,344
-5% -$563K 0.02% 757
2015
Q1 		$10.6M Buy
274,201
+9,580
+4% +$369K 0.02% 764
2014
Q4 		$8.91M Sell
264,621
-114,317
-30% -$4.04M 0.02% 819
2014
Q3 		$13.3M Sell
378,938
-60,623
-14% -$2.08M 0.03% 620
2014
Q2 		$14.4M Sell
439,561
-65,599
-13% -$2.24M 0.03% 595
2014
Q1 		$18.6M Sell
505,160
-90,664
-15% -$3.33M 0.04% 455
2013
Q4 		$22.9M Sell
595,824
-58,987
-9% -$1.86M 0.06% 383
2013
Q3 		$17.9M Sell
654,811
-51,405
-7% -$1.22M 0.05% 426
2013
Q2 		$14.8M Buy
+706,216
New +$13.8M 0.04% 457

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Parametric Portfolio Associates's WX Position: Q4 2015 in Review

Parametric Portfolio Associates sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 260,502 shares — an estimated $11.3M sold.

Parametric Portfolio Associates first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $22.9M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Parametric Portfolio Associates reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Parametric Portfolio Associates sold 260,502 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $11.3M.
  • Parametric Portfolio Associates first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Parametric Portfolio Associates's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $22.9M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Parametric Portfolio Associates's 13F filing for Q4 2015, filed 12 Feb 2016.